CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Significant Drop in Short Interest

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the recipient of a significant drop in short interest during the month of June. As of June 15th, there was short interest totaling 39,741 shares, a drop of 83.9% from the May 31st total of 246,664 shares. Based on an average daily trading volume, of 8,338,945 shares, the days-to-cover ratio is currently 0.0 days.

CBD Life Sciences Stock Performance

OTCMKTS:CBDL opened at $0.00 on Friday. CBD Life Sciences has a one year low of $0.00 and a one year high of $0.00.

About CBD Life Sciences

CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.

The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.